Researchers at Tulane University School of Medicine identified a gene that causes an aggressive form of breast cancer to rapidly grow. More importantly, they have also discovered a way to “turn it off” and inhibit cancer from occurring. The animal study results have been so compelling that the team is now working on FDA approval to begin clinical trials and has published details in the journal Scientific Reports.
- Berkeley Lab science snapshots
- New treatment targets found for blinding retinal disease
- KIST finds clue to improve artificial vision for patients with retinitis pigmentosa
- How to boost tips and donations with the dueling preference approach
- UT southwestern levels the playing field for testicular cancer patients